When investors balked at Zipline's "illegal" status in the U.S., the company launched in Rwanda. This constraint forced them to find a market with a powerful use case (blood delivery) and a government partner willing to create a legal framework, establishing a critical beachhead.

For health tech companies, Brazil is a powerful proving ground. Its large, self-contained private market operates very similarly to the U.S. system. Validating a product and business model in Brazil provides a strong signal and a potential pathway for successful expansion.

Before its US FDA filing, Sedana Medical established a strong commercial footprint in Europe, particularly Germany, where it serves over half of hospitals with ICUs. This real-world experience with hundreds of thousands of patients provides a robust proof-of-concept that de-risks the US launch for investors and potential customers.

A key lesson from Spotify CEO Daniel Ek is to first dominate a core market (music), then strategically "ladder" into adjacent areas (podcasts, audiobooks) that leverage the existing user base and interface. This methodical expansion builds on a position of strength rather than starting from scratch.

Unlike US startups serving one large market, Legora's Swedish origins necessitated immediate expansion into different countries with unique languages and laws. This built a core competency in multi-market operations, making global expansion a natural next step.

Instead of avoiding the EU's stringent regulations, startups can embrace them as a strategy. By tackling the hardest regulatory environment first, they build a compliant product that gives them a competitive advantage and makes future expansion into less-regulated markets much smoother.

Faced with complex U.S. regulations, Sure's founder went to South Africa. He leveraged its single-regulator system and his personal roots to land his first insurance partner. This validation then served as crucial social proof to sign the same company's U.S. division, de-risking a much larger market entry.

Spotify's early success stemmed from launching in smaller European countries where record labels had less focus. This allowed them to secure more favorable licensing deals and avoid the costly legal battles and poor margins that strangled their US-based competitors, enabling them to reach critical mass first.

Successfully launching in the U.S. market starts long before regulatory approval. Startups must pre-emptively map the entire adoption ecosystem—from patients to providers to clinicians—and develop tailored messaging for each stakeholder's unique priorities.